Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A Comprehensive Radiomics Model for Predicting Progression-Free Survival in High-Risk Neuroblastoma Based on CT Imaging.

Created on 12 Nov 2026

Authors

Jinrong Li, Sijie Gao, Bao Zhang, Wei Li, Ye Xu

Published in

The British journal of radiology. Nov 12, 2026. Epub Nov 12, 2026.

Abstract

This study evaluates the predictive utility of clinical features, CT imaging characteristics, radiomic features, and multimodal statistical models in estimating progression-free survival (PFS) in high-risk neuroblastoma (NB) patients.
105 pathologically confirmed high - risk NB patients per COG criteria were retrospectively selected and divided into training (80%) and test sets (20%). Statistical models were built using clinical variables, CT features, and radiomic features, with SVM algorithms employed. Five models were assessed, including radiomics, clinical + CT, clinical + radiomics, imaging + radiomics, and combined clinical + CT + radiomics models. A nomogram was constructed to predict PFS.
Univariate analysis found NSE > 200 μg/mL, LDH >1000 U/L, and MYCN amplification as significant poor - prognosis predictors (P < 0.05). Multivariate analysis confirmed MYCN amplification (P = 0.043) and IDRFs presence (P = 0.036) as independent risk factors. A radiomics model was built from CT scans' different phases. The combined model showed the best and most stable performance with AUC values of 0.855, 0.796, 0.856 in training, validation, and test cohorts. A nomogram integrating Rad - Score and clinical parameters from Cox regression was developed, with a C - index of 0.806 (P = 0.028) via bootstrap validation.
This study validates a PFS predictive model combining clinical, CT, and radiomic features, providing a robust tool for individualized prognosis in high-risk NB patients.
Radiomics demonstrates predictive utility for progression-free survival in pediatric patients with high-risk neuroblastoma.

PMID:
43016345
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement